Explore the Agenda
7:00 am Check In, Coffee & Light Breakfast
Workshop A
8:00 am Unlocking Value at the Intersection of EHS, Manufacturing Optimisation & Sustainability
As pharma and biotech organisations face pressure to increase productivity through AI, automation, and headcount reduction, there’s a growing need to connect the dots between EHS, continuous manufacturing, and sustainability. This closing panel will explore how aligning these areas can unlock operational value, enhance safety, and support long-term strategic goals.
Key Questions to Be Addressed:
- How can EHS leaders play a strategic role in productivity and transformation programs driven by AI and continuous manufacturing?
- What are the risks of overlooking EHS and sustainability in efforts to reduce FTEs and increase automation?
- How can organisations practically align safety, efficiency, and sustainability goals to realise measurable benefits?
- What leadership behaviours and structures are needed to bridge operational and EHS functions effectively?
11:00 am Morning Break & Refreshments
Workshop B
11:15 am Shaping AI in EHS: Opportunities, Limitations, & System Thinking Approach
This workshop is designed for leaders seeking practical insights into strategically integrating AI into EHS. We will address AI’s potential, deal with its practical challenges, and explore how it is connected within a holistic systems framework.
Highlights include:
- Explore AI’s vision and Realities
- Implement effective governance & manage risks
- Connect the dots with a system approach
*There will be a 30 minute break for lunch to be served during this workshop.
2:45 pm Afternoon Break & Refreshments
Workshop C
3:00 pm Enhancing Top-Down Leadership Accountability to Streamline Communication & Empower Safety Culture
Despite evolving regulations and increasing complexity in biopharma, this workshop emphasises that effective safety leadership must come from the top, not just the EHS department. Join us to explore practical strategies for building leadership accountability across all levels of the business.
Highlights include:
- How biopharma companies are shifting from EHS as a legal requirement to EHS as a leadership competency
- Creating safety leadership programs (e.g., behaviour-based safety, life-saving rules, leadership walk-throughs) that stick
- Building capability: Making sure senior leaders know not just what to do, but why it matters
- How visible, values-driven leadership in safety can strengthen trust, improve culture, and boost performance
- Benchmarking how top companies respond to incidents and how leadership presence makes or breaks safety culture